Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02924
#Chemistry #ChemBio #DrugDiscovery #Kinases

Interesting J. Med. Chem. paper by the group of Michael Waring. They developed alkynylpyridopyrimidinones that covalently target Cys775 of EGFR to allow development of #CovalentInhibitors even against the C797S resistance mutant. pubs.acs.org/doi/10.... #ChemSky #ChemBio #DrugDiscovery #Kinases

Insightful talk by Anthe Janssen at #NWOCHAINS. He talked about his research with Dompé Farmaceutica in the framework of #ChemistryNL on using #docking and #MachineLearning-assisted re-scoring to better predict compound binding affinity to #kinases.
https://pubs.acs.org/doi/10.1021/acs.jcim.4c01260
#Chemistry #ChemBio #DrugDiscovery
CC: @LED3hub

Insightful talk by Anthe Janssen at #NWOCHAINS. He talked about his research with Dompé in the framework of #ChemistryNL on using #docking and #MachineLearning-assisted re-scoring to better predict compound binding affinity to #kinases. pubs.acs.org/doi/10.1021/... #ChemSky #ChemBio #DrugDiscovery

A tour-de-force study by the group of Bernhard Küster (@[email protected]). They profiled 133 kinase inhibitors in 5 cell lines at 11 doses using #phosphoproteomics to identify 5,318 confident kinase::substrate relationships for 96 human #kinases www.biorxiv.org/content/10.1... #ChemSky #ChemBio

biorxiv.org/content/10.110...

Interesting paper by the group of Peter Tonge in @jacs.acspublications.org. They studied the #kinetics of non-covalent #BTK inhibitors. Clinical compounds showed increased residence times, while association rates were nearly constant. pubs.acs.org/doi/10.... #Kinases #DrugDiscovery #ChemSky #ChemBio

Modulating the Binding Kinetic...

Interesting paper by the group of Peter Tonge in JACS. They studied the detailed kinetics of non-covalent BTK inhibitors. Interesting insights that clinical compounds showed increased residence times, while association rates remained nearly constant. https://pubs.acs.org/doi/10.1021/jacs.5c07063
#Kinases #DrugDiscovery #Chemistry #ChemBio #BTK #Kinetics